Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	91.56	124.29	143.74	151.79	280.12	447.65
Short-Term Investments	504.87	657.04	606.35	847.12	677.95	230.42
Cash & Short-Term Investments	596.43	781.32	750.09	998.92	958.07	678.06
Cash Growth	-28.96%	4.16%	-24.91%	4.26%	41.30%	90.56%
Receivables	-	-	-	5.22	4.94	82.65
Prepaid Expenses	23.84	17.35	16.7	12.11	11.47	9.39
Other Current Assets	3.74	10.53	3.32	3.26	1.76	-
Total Current Assets	624.01	809.2	770.1	1,020	976.24	770.1
Property, Plant & Equipment	43.73	57.67	68.87	75.39	27.32	28.83
Other Intangible Assets	-	2.3	2.3	2.3	2.3	-
Other Long-Term Assets	2.26	2.12	2.71	2.58	2.58	0.9
Total Assets	670	871.3	843.98	1,100	1,008	799.83
Accounts Payable	2.75	14.1	9.21	10.58	8.28	6.35
Accrued Expenses	25.13	21.24	14.89	22.7	13.56	5.56
Current Portion of Leases	3.64	5.73	4.96	4.28	1.84	1.52
Current Unearned Revenue	-	7.68	-	-	0.25	-
Other Current Liabilities	1.08	1.99	1.2	26.15	0.4	0.2
Total Current Liabilities	32.61	50.73	30.27	63.71	24.32	13.63
Long-Term Leases	29.69	42.78	48.5	53.47	21.06	22.9
Other Long-Term Liabilities	-	-	13.21	32.38	65.26	0
Total Liabilities	62.29	93.5	91.98	149.55	110.64	36.54
Common Stock	0.17	0.17	0.13	0.12	0.11	0.09
Additional Paid-In Capital	2,567	2,517	2,153	2,019	1,667	1,167
Retained Earnings	-1,960	-1,738	-1,401	-1,059	-768.1	-404.23
Comprehensive Income & Other	0.49	-0.99	-0.2	-10.42	-1.09	0.06
Total Common Equity	607.71	777.79	752	950.22	897.81	763.29
Shareholders' Equity	607.71	777.79	752	950.22	897.81	763.29
Total Liabilities & Equity	670	871.3	843.98	1,100	1,008	799.83
Total Debt	33.33	48.5	53.47	57.74	22.9	24.42
Net Cash (Debt)	563.1	732.82	696.62	941.18	935.17	653.64
Net Cash Growth	-28.70%	5.20%	-25.98%	0.64%	43.07%	97.48%
Net Cash Per Share	3.31	5.13	5.68	8.39	9.83	15.34
Filing Date Shares Outstanding	173.32	169.52	131.18	121.38	108.28	90.32
Total Common Shares Outstanding	172.63	167.76	127.46	121.11	108.21	89.91
Working Capital	591.41	758.48	739.83	955.8	951.92	756.47
Book Value Per Share	3.52	4.64	5.90	7.85	8.30	8.49
Tangible Book Value	607.71	775.49	749.7	947.92	895.51	763.29
Tangible Book Value Per Share	3.52	4.62	5.88	7.83	8.28	8.49
Machinery	-	30.93	29.08	24.98	17.88	15.32
Construction In Progress	-	0.07	1.58	1.22	0.13	0.58
Leasehold Improvements	-	3.83	3.83	3.83	2.9	0.89

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q